Vertex Pharmaceuticals today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback